VEXT Vext Science, Inc.
Vext Science, Inc., through its subsidiaries, engages in integrated cannabis operations in the United States. It owns and manages cultivation facilities, manufacturing units, and dispensaries; and involves in the cultivation, extraction, manufacture, and sale of THC and CBD cartridges, concentrates, edibles, and extracts. The company also engages in the retail dispensary activities; and wholesale distribution of cannabis THC and hemp CBD products under the Vapen, Pure Touch, Appalachian Pharm, Herbal Wellness, Prism, Firebrand, and Revibe brands. The company was formerly known as Vapen MJ Ventures Corporation and changed its name to Vext Science, Inc. in November 2019. Vext Science, Inc. was incorporated in 2015 and is headquartered in Phoenix, Arizona.…
Industry Peers
Drug Manufacturers - Specialty & GenericKey Statistics
About Vext Science (CNSX: VEXT)
›
Vext Science (CNSX: VEXT) is listed on the Canadian Securities Exchange, where its shares trade in CAD. It belongs to the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector.
The shares were at 0.1850 CAD on 18 November 2026, down 48.6% over 52 weeks. Its 52-week range is 0.1750 CAD to 0.4000 CAD: the price is 53.7% below the high and 5.7% above the low.
Its market capitalisation is 45.83M CAD.
Vext Science reports return on equity of -32.5%, an operating margin of -10.8% and revenue up 17.6% year over year.
Its debt exceeds its cash by 33.24M USD, a debt-to-equity ratio of 0.63. Its Piotroski F-score is 6 out of 9, an average reading of its financial health. The next earnings report is expected on 19 November 2026.